| ST000593 PGD2 and other lipid mediator changes in mouse adipose associated with administration of an oral inhibitor of H-PGDS (HQL-79) | ||||
| Limit by pathway class: | ||||
| Pathway name (# of metabolites detected in this study) | HMDB pathway | KEGG pathway |
|---|---|---|
| Glycerolipid Metabolism (6) | SMP0000039 | map00561 |
